Since January 2013, he has served on the Board of Directors for Biscayne Pharmaceuticals, Inc., based in Miami Florida. Biscayne Pharmaceuticals, Inc. is a biopharmaceutical company that has discovered and developed novel therapies based on growth hormone-releasing hormone (GHRH) analogs.